Are Diabetes Prevention Treat-ments Truly Disease Modifying?

August 2011
Internal Medicine Alert;Aug2011 Clinical Briefs in Primary, p16
The article reports on the Heart Outcomes Prevention Evaluation trial that aims to reduce conversion from pre-diabetes to type 2 diabetes (DM2).


Related Articles

  • Possibilities for prevention. Rafkin, Lisa // Countdown;Summer98, Vol. 19 Issue 3, p18 

    Focuses on the Diabetes Prevention Trial-Type 1 (DPT-1), a randomized clinical trial conducted in the United States designed to determine whether it is possible to prevent or delay the onset of Type 1 diabetes. Sponsors of the trials; Eligible participants in the insulin injection trial.

  • Prevention trial for Type I diabetes.  // Diabetes Forecast;Sep95, Vol. 48 Issue 9, p77 

    Calls for participants to a study launched by the National Institutes of Health to test whether daily insulin injections will prevent diabetes. Genetic risks of developing type I diabetes; Eligible participants; Steps on how to participate.

  • Prevention of Diabetes.  // OB/GYN Clinical Alert;Sep2012 Clinical Briefs in Primary Care, p18 

    The article discusses the clinical trials of various drugs such as metformin and thiazolidinedione for the prevention of diabetes.

  • Interferon Alpha Can Delay Full Onset of Type 1 Diabetes.  // Diabetes Health;Oct/Nov2009, Vol. 18 Issue 5, p38 

    The article reports on a phase II clinical trial performed at the University of Texas Medical School which revealed that a low dose of oral interferon alpha can delay the full onset of type 1 diabetes.

  • Prevention of type 2 diabetes. Narayan, K M Venkat; Bowman, Barbara A; Engelgau, Michael E // BMJ: British Medical Journal (International Edition);7/14/2001, Vol. 323 Issue 7304, p63 

    Editorial. Discusses a randomised controlled clinical trial in Finland which studied prevention of type two diabetes. Behavioural and environmental factors which have been linked to type two diabetes, such as overweight, physical inactivity, and dietary habits; Conclusion of the report that...

  • TRIGR: First ever trial for the primary prevention of T1D.  // Diabetes Digest;2011, Vol. 10 Issue 3, p141 

    The article discusses a Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study by H. K. Akerblom and colleagues on whether weaning babies with high hydrolised formula can reduce the risk of type 1 diabetes (T1D).

  • Go4it; study design of a randomised controlled trial and economic evaluation of a multidisciplinary group intervention for obese adolescents for prevention of diabetes mellitus type 2. Bovet, Pascal; Gervasoni, Jean-Pierre; Mkamba, Mashombo; Balampama, Marianna; Lengeler, Christian; Paccaud, Fred // BMC Public Health;2008, Vol. 8 Issue 1, p410 

    Background: In the Netherlands, the first adolescents with diabetes mellitus type 2 as a result of obesity have recently been diagnosed. Therefore, it is very important that programs aiming at the prevention of type 2 diabetes of obese adolescents are developed and evaluated. Methods: Go4it is a...

  • NIH funds large study on the effects of weight loss and exercise on type 2 diabetes.  // Healthy Weight Journal;Nov/Dec2001, Vol. 15 Issue 6, p83 

    Provides information on a randomized clinical trial designed to examine the effects of a lifestyle intervention program on heart attack, stroke and cardiovascular-related death in people with type 2 diabetes, funded by the National Institute of Diabetes and Digestive and Kidney Diseases. ...

  • Home Blood Glucose Monitoring in Type 2 Diabetes. HIRSCH, IRI B. // Diabetes Care;Feb2011, Vol. 34 Issue 2, p527 

    The author discusses a study on self-monitoring blood glucose (SMBG) used in the Diabetes Control and Complications Trial. The SMBG was considered the standard of care for type 1 diabetic patients after the DCCT in 1993. The author says that the same results were obtained for insulin-requiring...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics